2021 | Influence of C Upsilon P2C9 Genetic Polymorphisms on the Pharmacokinetics of Losartan and Its Active Metabolite E-3174: A Systematic Review and Meta-Analysis | 곽혜선 | Review |
2018 | Intestinal P-glycoprotein inhibitors, benzoxanthone analogues | 이화정; 권영주; 이재옥 | Article |
2019 | Pharmacokinetic Alteration of Paclitaxel by Ferulic Acid Derivative | 박혜영; 이화정; 이정연; 이재옥 | Article |
2019 | Pharmacokinetic Study of NADPH Oxidase Inhibitor Ewha-18278, a Pyrazole Derivative | 배윤수; 이화정; 이재옥 | Article |
2018 | Population pharmacokinetic analysis of propofol in underweight patients under general anaesthesia | 이은경 | Article |
2021 | Population pharmacokinetic analysis of ropivacaine extended-release from a temperature-responsive hydrogel in rats | 이은경 | Article |
2016 | Population pharmacokinetics and prophylactic anti-emetic efficacy of ramosetron in surgical patients | 이은경 | Article |
2017 | Prediction of serum theophylline concentrations and cytochrome P450 1A2 activity by analyzing urinary metabolites in preterm infants | 박은애 | Article |
2019 | Predictive performance of a new pharmacokinetic model for propofol in underweight patients during target-controlled infusion | 이은경 | Article |
2022 | Predictive performance of pharmacokinetic models for target concentration-controlled infusion of cefoxitin as a prophylactic antibiotic in patients with colorectal surgery | 이은경 | Article |
2017 | Predictive performance of the modified Marsh and Schnider models for propofol in underweight patients undergoing general anaesthesia using target-controlled infusion | 이은경 | Article |
2022 | The expected advantage of administering prophylactic antibiotics using target- concentration controlled infusion: Development of a new pharmacokinetic model of cefazolin | 이은경 | Article |
2020 | Vancomycin pharmacokinetics in critically ill neonates receiving extracorporeal membrane oxygenation | 곽혜선; 이은미 | Article |